|
 |
HumiraThis page contains recent news articles, when available, and an overview of Humira but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....of Centocor Ortho Biotech, Centocor has filed a new suit seeking continuing damages against Abbott for its manufacture of the arthritis drug Humira®. ... Patent Docs (blog) Abbott's rise might be in for long run for investors - Jan 2, 2010 Abbott's growth prospects come down to two products, Humira, an inflammation fighter for arthritis that could have potential in combatting Crohn's disease, ... Chicago Sun-Times Abbott Settles University of Iowa Humira Royalty Case - Dec 23, 2009 23 (Bloomberg) -- Abbott Laboratories, the drugmaker challenging a $1.67 billion patent verdict won by Johnson & Johnson over the arthritis medicine Humira, ... BusinessWeek A New Ulcerative Colitis Biologic With a Novel Mechanism of Action Would Earn ... - Jan 4, 2010 ..."Although clinical trial data are limited, interviewed experts believe that both Humira and Simponi's fully human composition will translate into ... PR Newswire (press release) Abbott Labs a winner - Jan 3, 2010 Third-quarter profits rose 37 percent due to sales increases of its rheumatoid arthritis medication Humira and nutritional products such as baby formula. ... Worcester Telegram CORRECTED - UPDATE 1-Celgene psoriasis drug shows promise in trial - Dec 16, 2009 Enbrel has shown PASI-75 scores of up to 47 percent, while Humira and Remicade have shown PASI-75 scores in the 65-80 percent range, said Meacham. ... Reuters Centocor's $1.67B Court Win Versus Abbott Upheld - Dec 18, 2009 J&J had alleged that Abbott's rheumatoid arthritis therapy Humira infringed a on patent that J&J's Centocor Ortho Biotech unit held for rival treatment ... Wall Street Journal Decade in Review: 2003 - Dec 27, 2009 Federal regulators approve Humira, a rheumatoid arthritis drug developed by Abbott Bioresearch Center in Worcester that will go on to post more than $1 ... Worcester Telegram Roche and Biogen's Blockbuster Making Good Progress - Dec 11, 2009 For rheumatoid arthritis patients, Rituxan is only approved for patients who have failed an anti-TNF alpha treatment: Enbrel, Humira, and Remicade. ... Motley Fool Money briefs - Dec 24, 2009 Abbott Laboratories, the drug-maker challenging a $1.67 billion patent verdict won by Johnson & Johnson over the arthritis medicine Humira, settled a ... Worcester Telegram Reduced Volume Eases Sting Of Mostly Down Day and Abbott's Strength Comes On ... - Dec 14, 2009 One reason Humira is starting to see growth now - despite being on the market for a while - is because dermatologists tend to be a bit conservative, ... Financial News USA (press release) TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed ... - Dec 13, 2009 ..."Our analysis of patient-level claims data shows that both Remicade and Abbott's Humira contributed to the increased uptake of TNF-alpha inhibitors in newly ... Melodika.net Geraldine man's life improved - Dec 15, 2009 He has been taking the newly subsidised Humira arthritis drug and has noticed an improvement in his condition. The pain hasn't gone, but month-by-month he ... Timaru Herald Abbott Labs Ordered to Pay $175 Million Pre-judgment Interest - Dec 23, 2009 7070775 with respect to its sale of the popular arthritis drug Humira. I guess when you lose a paltry $175.6 million, which relates only to the pre-judgment ... IPWatchdog.com New Year's Resolutions for the Drug Industry - Jan 1, 2010 We will stop selling biologics like Humira, which cause cancer and infections like TB, to perfectly healthy college kids with Crohn's disease-scare ... The Epoch Times Some Incyte Into Why These Drugs Rock - Dec 22, 2009 One reason: The major competition -- Abbott Labs' (NYSE: ABT) Humira, Johnson & Johnson's (NYSE: JNJ) and Merck's (NYSE: MRK) Remicade, and Pfizer's (NYSE: ... Motley Fool New Market Research Report from BioTrends Provides Insight on How ... - Dec 14, 2009 To be eligible for the audit, patients had to currently be treated with a biologic agent (UCB's Cimzia, Amgen/Wyeth's Enbrel, Abbott's Humira, Bristol Myers ... PR Newswire (press release) In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics ... - Dec 16, 2009 Additionally, Abbott/Eisai's TNF-alpha inhibitor Humira will also lose substantial market share to Stelara. However, the report finds that other biologics ... PR Newswire (press release) New and Upcoming Biologic Agents for Rheumatoid Arthritis - Dec 29, 2009 The first agents developed include TNF-æ±? blockers, infliximab (Remicade, Centocor), etanercept (Enbrel, Amgen), and adalimumab (Humira, Abbott) and the ... Ortho SuperSite Anti-smoking drugs in health basket - Dec 23, 2009 Avonex, Aricept, Exelon, Provigil and Targin for neurology; Byetta and Victoza for diabetes; Humira, Enbrel, Remicade and Amevive for dermatology; ... Jerusalem Post Martha Rosenberg: New Year's Resolutions for the Drug Industry for 2010 - Dec 29, 2009 We will stop selling biologics such as Humira that cause cancer and infections such as TB to perfectly healthy college kids with Crohn's disease scare ... BuzzFlash (blog) Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent ... - Dec 23, 2009 ...indicate that over 40% of their current patients on these newest TNF agents were switched from the current market share leaders Enbrel and Humira. ... PR Newswire (press release) Viron granted U.S. Patents for Organ Transplant and Arthritis Drug Candidates - Dec 22, 2009 Viron's second therapeutic candidate, VT-346, is a powerful inhibitor of TNF-a, the therapeutic target of Enbrel(TM), Humira(TM), Cimzia(TM) and ... PR Newswire (press release) Weekly Roundup - Dec 11, 2009 This would further boost the company's cholesterol franchise, and highlights its pipeline beyond its lead drug, Humira. Shares continue to rise as investors ... TheStreet.com (subscription) 2009 Big Pharma DOTY Nominee: Abbott/Solvay and the Foreign Cash Dilemma - Dec 17, 2009 ...and with the $6.9 billion acquisition of Knoll in 2001, Abbott gained Humira, a drug that today generates more than $4 billion a year. ... The IN VIVO Blog (blog) Money Briefs - Dec 15, 2009 The company's top product is the arthritis drug Humira, which had $4.5 billion in 2008 sales. BOSTON — After about a month of holding steady, the price of a ... Worcester Telegram Updates on Industrial and Pharma Holdings - Dec 11, 2009 Most investors focus on Humira, which has been a blockbuster drug for the company, but many other areas are equally as exciting for ABT, and its recent ... TheStreet.com (subscription) Abbott Continues to Expand - Dec 15, 2009 With these deals, we believe Abbott is looking to diversify its product portfolio so that it can reduce its dependence on Humira, which contributed $4.5 ... Zacks.com Biogen's RA Candidate Effective - Analyst Blog - Dec 14, 2009 Once launched, the product will compete with currently available treatments such as Pfizer/Amgen's (PFE/AMGN) Enbrel, Abbott's (ABT) Humira and Johnson ... Benzinga Abbott recebe do GRUPEMEF prêmio Lupa de Ouro em três categorias - Dec 22, 2009 O programa da área de RH "Conte Comigo" ea campanha Humira - Você Pode Mais receberam a Lupa de Ouro (1º. Lugar), prêmio máximo outorgado, pelo 33º. ano ... Portal Nacional de Seguros Nova droga contra psorÃase apresenta resultados promissores - Dec 16, 2009 Outros inibidores de TNF incluem o Humira, fabricado pela Abbott Laboratories Inc, eo Remicade, da Johnson & Johnson. ... O Globo Jueces ordenan a Salud suministrar medicamento a paciente pobre - Dec 15, 2009 La orden impuesta al organismo provincial está referido al suministro de una jeringa prellenada de 8 ml. de humira 40 mg (droga adalumimab) ya realizar las ... El Ciudadano (Bariloche) Abbott's Humira OKd for Crohn's. - Feb 28, 2007 Feb. 28--Abbott Laboratories' blockbuster drug Humira has been approved to treat adult patients with "moderately to severely active Crohn's disease," the ... Free with registration - Chicago Tribune - AccessMyLibrary.com FDA OKs 2 New Uses for Arthritis Drug Humira - Oct 5, 2005 By Jennifer Warner. The drug, which was previously approved to treat rheumatoid arthritis in 2002, is now also approved to treat psoriatic arthritis, ... FOXNews Cancer risk rises in arthritis drug study ; Humira, Remicade makers... - May 17, 2006 Rheumatoid arthritis patients taking Abbott Laboratories' blockbuster drug Humira or Johnson & Johnson's Remicade face triple the risk of developing several ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Bayer Sues Abbott Over Humira - Dec 30, 2008 By TSC Staff 12/30/08 - 04:18 PM EST. A unit of German drug maker Bayer is accusing Abbott Laboratories (ABT Quote) of patent infringement related to a ... TheStreet.com - TheStreet.com (subscription) ROUNDUP Cambridge Antibody, Abbott settle Humira royalty spat; CAT … - Oct 26, 2005 LONDON (AFX) - Cambridge Antibody Technology Group PLC and Abbott Laboratories settled their protracted battle over royalty payments for the rheumatoid ... Forbes US FDA says ad for Abbott's Humira downplays risks - Dec 24, 2008 WASHINGTON, Dec 23 (Reuters) - An advertisement for Abbott Laboratories' (ABT.N: Quote, Profile, Research) Humira minimizes the arthritis drug's risks while ... Reuters India Abbott says 2nd trial shows Humira eases psoriasis - Feb 2, 2007 LOS ANGELES, Feb 2 (Reuters) - A second Phase III trial has found that treatment with Abbott Laboratories Inc.'s (ABT.N) rheumatoid arthritis drug Humira ... Reuters Abbott tops forecast; Humira takes center stage - Jul 16, 2008 By Ransdell Pierson. NEW YORK (Reuters) - Abbott Laboratories Inc (ABT.N) on Wednesday said second-quarter earnings jumped 34 percent, beating expectations, ... Reuters UK Abbott's Humira helps fight Crohn's ; Arthritis medicine eased... - May 23, 2006 Humira's competition is Remicade, made by Johnson & Johnson. Remicade, with $3.13 billion in worldwide sales last year, was approved for adult treatment of ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Humira Relieves Crohn's Disease Symptoms - Feb 1, 2005 By Jeanie Lerche Davis. For people with Crohn's disease (search), Humira (search) may be effective when Remicade (search) no longer helps, new research ... FOXNews Abbott's Humira tames Crohn's in 29 pct of patients - May 21, 2008 By Ransdell Pierson. NEW YORK, May 21 (Reuters) - Abbott Laboratories Inc (ABT.N) said on Wednesday its Humira medicine has maintained maximum effectiveness ... Reuters Abbott profit rises as Humira, other drugs shine - Jul 18, 2007 NEW YORK, July 18 (Reuters) - Abbott Laboratories Inc. (ABT.N) posted higher second-quarter earnings Wednesday on increased sales of its prescription drugs, ... Reuters Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for … - Jun 7, 2006 ABBOTT PARK, Ill., June 7 /PRNewswire-FirstCall/ -- Abbott announced that it has received approval from the European Commission to market HUMIRA(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Abbott Labs' profits up, but Humira sales disappoint analysts - Apr 13, 2005 Strong pharmaceutical sales helped drive first-quarter profit up nearly 10 percent at Lake County-based Abbott Laboratories. ... $2.95 - Chicago Sun-Times - NewsBank Abbott: EU approves Humira for moderate-to-severe plaque psoriasis - Dec 20, 2007 SAN FRANCISCO (Thomson Financial) - Abbott Laboratories said Thursday the European Commission granted marketing authorization for the use of Humira to treat ... Forbes Abbott's Humira treatment for AS arthritis gets positive opinion from... - Apr 28, 2006 LONDON (AFX) - Abbott Laboratories said the scientific committee of the European Medicines Agency has issued a positive opinion recommending its Humira ... Forbes Eisai, Abbott Win Japanese Approval for Humira Drug - Apr 16, 2008 By Simeon Bennett. April 16 (Bloomberg) -- Eisai Co. and Abbott Laboratories won Japanese approval to sell the rheumatoid arthritis treatment Humira today, ... Bloomberg Abbott's Humira gets positive opinion from EMEA for psoriasis... - Nov 16, 2007 NEW YORK (Thomson Financial) - Abbott Laboratories Friday said the scientific committee of the European Medicines Agency, the Committee for Medicinal ... Forbes Humira approved as spinal treatment - Market expands for Worcester- … - Aug 1, 2006 Federal regulators have approved Abbott Laboratories' drug Humira to treat an inflammatory disease of the spine, a move that expands the market for the drug ... $1.95 - Worcester Telegram Gazette - NewsBank Abbott's Humira extends reach with EU Crohn's okay - Apr 27, 2007 LONDON, April 27 (Reuters) - Abbott Laboratories Inc.'s (ABT.N) established arthritis drug Humira has been recommended for approval in Europe for treating ... Reuters FDA approves Humira to treat psoriasis - Jan 18, 2008 NORTH CHICAGO, Ill.—Drug and device maker Abbott Laboratories said Friday it received US approval to market its drug Humira for a new use against a severe ... Boston Globe … receives expanded FDA approval for Humira psoriatic arthritis... - Nov 14, 2006 ABBOTT PARK, Illinois (AFX) - Abbott Laboratories Inc said the US Food and Drug Administration has expanded its approval of the company's anti-inflammatory ... Forbes Abbott seeks US and EU approvals for Humira as a treatment for... - May 9, 2007 Abbott has announced it has simultaneously submitted a supplemental Biologics License Application (sBLA) with the US Food and Drug Administration (FDA) and ... News-Medical.net Abbott Receives FDA Approval for Humira (Adalimumab) for Polyarticular... - Feb 22, 2008 ABBOTT PARK, Ill., February 22, 2008 /PRNewswire-FirstCall/ -- Abbott announced today it has received US Food and Drug Administration (FDA) approval to ... FierceBiotech Study boosts Humira - Dec 30, 2005 Abbott Laboratories' Humira is effective as a first treatment for patients with aggressive rheumatoid arthritis, according to a company-funded study in the ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Abbott trying to get Humira approved for additional use - Apr. 2, 2007 - Apr 2, 2007 By Aaron Smith, CNNMoney.com staff writer. NEW YORK (CNNMoney.com) -- Abbott Laboratories is trying to get its top-selling blockbuster drug approved for yet ... CNNMoney.com Abbott's Profit Tops Estimates, Led by Humira, Xience (Correct) - Oct 16, 2008 By Tom Randall. (Corrects attribution of remarks in the 16th and 17th paragraphs of story published on Oct. 15.) Oct. 15 (Bloomberg) -- Abbott Laboratories ... Bloomberg New Phase III Data Show Abbott's HUMIRA (REG) (adalimumab) Was … - Oct 6, 2006 Positive Phase III data presented today at the European Academy of Dermatology and Venereology (EADV) Congress showed that HUMIRA® was statistically ... Medical News Today - Medical News Today (press release) Humira expected to keep Abbott's net in good health - Oct 17, 2007 Abbott's growing lineup of drugs for either suppressing the "bad" form of cholesterol or boosting blood levels of the "good" form, known as high-density ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Abbott Has Fourth-Quarter Profit on Demand for Humira - Jan 23, 2008 By Elizabeth Lopatto. Jan. 23 (Bloomberg) -- Abbott Laboratories posted a fourth quarter profit, fueled by demand for its anti-inflammatory drug Humira. ... Bloomberg Strong Humira sales help lift Abbott to 3.2% gain - Apr 20, 2006 Profit is getting a boost from Humira, whose sales jumped 39 percent, to $392 million, and from [Abbott]'s Kaletra HIV drug, whose sales climbed 18 percent, ... Pay-Per-View - Chicago Tribune - ProQuest Archiver HUMIRA(R) (Adalimumab) Data Show That Treating Early Rheumatoid … - Jun 13, 2008 PARIS, June 13 /PRNewswire-FirstCall/ -- New data announced today showed that treating patients with early, active rheumatoid arthritis (RA) with Abbott's ... RedOrbit Abbott says new uses may greatly lift Humira sales - Jul 18, 2007 NEW YORK, July 18 (Reuters) - Abbott Laboratories Inc. (ABT.N) on Wednesday said future new uses of its Humira arthritis drug, possibly including asthma and ... Reuters Abbott's Net Rises 5 Percent as Sales Surge on Humira - Oct 18, 2006 By Duncan Moore. Oct. 18 (Bloomberg) -- Abbott Laboratories' third-quarter earnings rose 5 percent as sales of its best-selling drug, Humira, surged after ... Bloomberg Abbott profits slide on cost cutting - shares rise: Humira helps... - Oct 20, 2005 Abbott Laboratories, which cut 700 jobs here in July, told workers in its global manufacturing operations Wednesday an unspecified number of additional cuts ... $2.95 - Chicago Sun-Times - NewsBank Abbott's Humira wins European approval as treatment of Crohn's disease - Jun 7, 2007 ABBOTT PARK, Illinois (Thomson Financial) - Abbott Laboratories Inc said it has received approval from the European Commission to market Humira as treatment ... Forbes CAT cuts losses after settlement - Nov 28, 2005 ..."The royalty stream from Humira and our balance sheet strength provide firm ... Abbott will pay CAT royalties of 2.688pc on sales of Humira from January 1, ... Telegraph.co.uk Abbott's HUMIRA® Receives FDA Approval for Inhibiting Structural... - Nov 15, 2006 Abbott announced today that the US Food and Drug Administration (FDA) approved an expanded indication for HUMIRA® (adalimumab) that includes inhibiting ... Medical News Today - Medical News Today (press release) UK health watchdog recommends Abbott's Humira for psoriasis if other ... - Jun 24, 2008 LONDON (Thomson Financial) - The UK's healthcare spending watchdog, the National Institute for Health and Clinical Excellence (NICE), has recommended the ... Forbes Humira wins expanded OK in Europe - Aug 16, 2005 Abbott Laboratories landed European regulatory approval to market its blockbuster rheumatoid arthritis drug Humira to treat early stages of the disease and ... $2.95 - Chicago Sun-Times - NewsBank Earnings Roundup; Humira boosts Abbott's results - Jul 17, 2008 Abbott Laboratories' second-quarter profit rose 34% as its top-selling product, anti-inflammatory medicine Humira, was approved for new uses. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver European Commission OKs Humira as psoriasis treatment - Dec 21, 2007 Abbott Laboratories said Thursday that the European Commission approved the marketing of Humira as a treatment for moderate to severe forms of the skin ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Abbott seeks Crohn's indication for Humira - Sep 7, 2006 ABBOTT PARK, Ill., Sept. 7 (UPI) -- Abbott said Thursday it filed with US and European regulatory authorities seeking a Crohn's disease use for Humira. ... United Press International Abbott Revenue Jumps 16% - Apr 12, 2005 Sales at Abbott's pharmaceutical products unit increased 20.1% to $1.87 billion, with strong sales of Humira, Kaletra, Biaxin, Depakote and Mobic. ... TheStreet.com - TheStreet.com (subscription) Abbott says Humira helps Crohn's patients - Oct 23, 2006 LOS ANGELES – Abbott Laboratories Inc. said Monday that its rheumatoid arthritis drug Humira has been shown to help patients with Crohn's disease who do not ... San Diego Union - Tribune - San Diego Union Tribune FDA reviews Enbrel, Humira and Remicade - Jun 4, 2008 WASHINGTON, June 4 (UPI) -- The US Food and Drug Administration has announced a safety review of several drugs known as tumor necrosis factor, or TNF, ... United Press International Abbott's Humira shows promise in combo - Jun 9, 2005 Abbott Laboratories' rheumatoid arthritis drug Humira significantly reduced disease progression and brought about remission in many patients when taken with ... $2.95 - Chicago Sun-Times - NewsBank … for those suffering from Crohns, FDA approves Humira for patients... - Mar 20, 2007 Beyond Remicade and Humira, several other drugs work similarly and are undergoing trials for treatment of Crohn's. These include Cimzia, produced by Belgian ... Pay-Per-View - Newsday - ProQuest Archiver FDA APPROVES PEN INJECTION FOR ARTHRITIS DRUG HUMIRA - Jun 27, 2006 The Food and Drug Administration approved a simpler way for people to take Humira, an arthritis medication manufactured in Worcester by Abbott Laboratories. ... $2.95 - Boston Globe - NewsBank Humira, Cimzia, Enbrel and Remicade to Bear Stronger Infection … - Sep 4, 2008 Federal regulators have ordered the makers of Humira, Cimzia, Enbrel, and Remicade to strengthen the existing warnings about opportunistic fungal infections ... Newsinferno.com Abbott set for Humira sales leap - Worcester plant makes booming … - Oct 12, 2005 WORCESTER - Abbott Laboratories is prepared to meet increased demand for Humira, a rheumatoid arthritis drug, with production at the company's Worcester ... $1.95 - Worcester Telegram Gazette - NewsBank Abbott Earnings Rise 8.8% on Strong Sales of 2 Drugs - Jan 19, 2005 Sales of Humira were up 130 percent in the quarter, and sales of Mobic, a nonsteroidal anti-inflammatory, rose 176 percent. ... New York Times Humira grabbing market share for Abbott - Sep. 6, 2006 - Sep 6, 2006 By Aaron Smith, CNNMoney.com staff writer. NEW YORK (CNNMoney.com) -- Abbott Labs' fast-growing flagship drug Humira is grabbing market share and making ... CNNMoney.com Tests Clear Gene Therapy of Jolee Mohr's Death, but Targeted Genetics... - Nov 12, 2007 Humira is indicated only for patients with moderate-to-severe disease, so if you need to be maintained on stuff like Humira to remain symptom-free, ... Wired News ABT Gets a Hand From Its Non-Pharma Businesses - Apr 16, 2008 The growth in Humira should continue to grow as more scripts are written and more indications ... One of the highlighted products in the quarter was Humira, ... TheStreet.com - TheStreet.com (subscription) Psoriasis patients receiving HUMIRA® (adalimumab) achieved significant... - Feb 22, 2005 Psoriasis patients receiving HUMIRA® (adalimumab) achieved significant improvement in disease activity and quality of life through 60 weeks of treatment, ... i-newswire.com FDA Reviews Arthritis Drugs for Links to Cancer - Jun 5, 2008 Remicade, Humira and Enbrel had combined sales of more than $13 billion last year ... Enbrel and Humira are approved to treat juvenile idiopathic arthritis, ... New York Times Update on a Drug Play | Action Alerts PLUS News | Print Financial & … - Oct 30, 2008 The growth behind Abbott comes from its flagship drug Humira, ... Humira is a medicine called a tumor necrosis factor (TNF) inhibitor that basically blocks ... TheStreet.com - TheStreet.com (subscription) Abbott Laboratories 1Q Profit Declines - Apr 18, 2007 Revenue rose 16 percent to $5.29 billion from $4.58 billion last year, driven by sales of the anti-inflammatory drug Humira of $571 million, ... San Francisco Chronicle Abbott's Humira superior to methotrexate in treating psoriasis -... - Oct 5, 2006 RHODES, Greece - Abbott's Humira drug is 'statistically superior' to methotrexate in treating patients with psoriasis, the company said, citing positive ... Forbes Adalimumab (Humira) Shows Efficacy for Ankylosing Spondylitis: … - Nov 17, 2005 By Bruce Sylvester. SAN DIEGO, CA -- November 17, 2005 -- Adalimumab (Humira) appears to be effectively treat the signs and symptoms ankylosing spondylitis ... DG News Humira Not Enough to Salvage Abbott's Quarter - May 1, 2007 Pharma and drug company Abbott Laboratories (ABT - commentary - Cramer's Take) will be reporting its third-quarter 2007 earnings on Oct. 17. ... TheStreet.com - TheStreet.com (subscription) Abbott looking to Humira for psoriasis sales - Feb 8, 2007 Abbott Laboratories, armed with a drug it says delivers better results and is easier to take, hopes to take sales from Amgen Inc. in the $3 billion-a-year ... Pay-Per-View - Chicago Tribune - ProQuest Archiver AstraZeneca closes in on £600m deal for CAT - May 15, 2006 CAT has a long - and fraught - relationship with Abbott, which has the licence to sell its blockbuster drug to treat rheumatoid arthritis, Humira. ... Independent Abbott (ABT) Receives FDA Approval for the HUMIRA Pen - Jun 26, 2006 Abbott (NYSE: ABT) announced that the US Food and Drug Administration (FDA) approved the HUMIRA Pen, a new device for administering HUMIRA, ... StreetInsider.com - StreetInsider.com (subscription) Study: Abbott s Humira Effective For Juvenile Arthritis - Nov 11, 2006 CHICAGO -(Dow Jones)- Humira, a drug made by Abbott Laboratories Inc. (ABT), has proven effective in treating children with juvenile rheumatoid arthritis, ... CNNMoney.com 1 in 4 new bio meds cause serious side effects - Oct 21, 2008 Included in the report released Tuesday were the arthritis drugs Humira and Remicade, cancer drugs Rituxan and Erbitux, and the heart failure drug Natrecor. ... msnbc.com Article: Abbott says Humira works on psoriasis - Chicago Sun-Times | ... - Apr 3, 2007 Abbott says Humira works on psoriasis ... find Chicago Sun-Times articles. Abbott Laboratories said its Humira arthritis drug was successful against ... Pay-Per-View - Chicago Sun-Times - HighBeam Research FDA reviewing arthritis drugs for cancer link - Jun 4, 2008 The drugs under review include Abbott Labs' Humira, Schering-Plough's ... Abbott's Humira was the company's best-selling product last year with over $3 ... msnbc.com … Antibody and Abbott Laboratories report increased sales of Humira. - Jan 19, 2005 In the pharmaceuticals sector, Cambridge Antibody rose 10p to 725p after Abbott Laboratories boasted of forecast-beating sales of its Humira product. ... Pay-Per-View - Independent - Factiva, from Dow Jones Strong Humira sales help lift Abbott to 3.2 percent gain. | Article... - Apr 20, 2006 Strong Humira sales help lift Abbott to 3.2 percent gain. ... find Chicago Tribune (Chicago, IL) articles. Byline: James P. Miller Apr. 20--Abbott ... Pay-Per-View - Chicago Tribune - HighBeam Research Abbott's HUMIRA(R) (Adalimumab) Granted FDA Priority Review for the … - Oct 26, 2006 ABBOTT PARK, Ill., Oct. 26 /PRNewswire-FirstCall/ -- Abbott announced today that the US Food and Drug Administration (FDA) has granted Priority Review for ... Free with registration - PR Newswire - AccessMyLibrary.com Humira Not Enough to Salvage Abbott's Quarter - May 1, 2007 Last quarter, operating margins for Abbott almost doubled to 18.6%, due to 16% revenue growth driven by the Guidant acquisition. ... TheStreet.com - TheStreet.com (subscription) Humira Not Enough to Salvage Abbott's Quarter - Oct 17, 2007 By Vasu Vijayraghavan. While Abbott Laboratories (ABT - commentary - Cramer's Take) has some trump cards in its current product portfolio, as well as some ... TheStreet.com - TheStreet.com (subscription) CAT chief pockets £3.5m as takeover by AZ is sealed - May 16, 2006 CAT, which is still loss-making, sold the marketing right to Humira to Abbott Laboratories, the US drug maker. The company is working on a range of ... Times Online Robust Humira sales strengthen Abbott net earnings. | Article from … - Apr 13, 2005 Robust Humira sales strengthen Abbott net earnings. ... find Chicago Tribune (Chicago, IL) articles. Byline: Bruce Japsen Apr. 13--Abbott Laboratories ... Pay-Per-View - Chicago Tribune - HighBeam Research Abbott Labs drops on outlook, despite strong quarter - MarketWatch - Jul 13, 2005 Sales of Humira rocketed 58% to $321 million in the quarter and the company backed an outlook for sales of more than $1.3 billion from the product for 2005. ... MarketWatch Abbott Labs' Profit Falls 30% but Beats Estimates - Jul 20, 2006 Humira came in about $28 million above our estimates,â€? said Phil Nalbone, an analyst at RBC Capital Markets, adding that a lower tax rate also helped ... New York Times Humira Approved for the Treatment of Ankylosing Spondylitis - Aug 2, 2006 Abbott Labs announced this week that the TNF-inhibitor drug, Humira, has now been approved for the treatment of ankylosing spondylitis (AS). ... HealthCentral.com Abbott Sees Higher Profit After Fourth-Quarter Loss - Jan 24, 2007 Sales of Abbott's top-selling drug, the arthritis treatment Humira, increased 40 ... Humira sales were helped last year by winning additional US regulatory ... Bloomberg Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate … - Jan 19, 2008 Abbott (NYSE: ABT) announced it has received US Food and Drug Administration (FDA) approval to market HUMIRA(R) (adalimumab) as a treatment for adult ... Medical News Today - Medical News Today (press release) Humira gets go-ahead for the treatment of ankylosing spondylitis - Jun 9, 2006 Abbott has been given the green light to market Humira in Europe for the treatment of severe active ankylosing spondylitis. ... Pharmafocus Abbott's HUMIRA (adalimumab) shows promising results in long-term … - Oct 31, 2005 Data from an analysis of 55 patients with moderate to severely active Crohn's disease who achieved clinical remission through treatment with Humira ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com Abbott receives approval for HUMIRA (Adalimumab) for polyarticular … - Feb 26, 2008 Abbott has announced that it has received US Food and Drug Administration (FDA) approval to market HUMIRA (adalimumab) as a treatment to reduce signs and ... News-Medical.net Humira shows psoriasis promise - Feb 3, 2007 LIBERTYVILLE TOWNSHIP - Abbott Laboratories' top-selling drug, Humira, significantly reduced the presence of scaly, red skin lesions in psoriasis patients, ... $4.95 - Daily Herald - ECNext Three Studies Suggest Abbott's HUMIRA(R) (Adalimumab) May Improve … - Jun 15, 2007 BARCELONA, Spain, June 15 /PRNewswire-FirstCall/ -- Rheumatoid arthritis (RA) is one of the most common causes of disability in the Western world. ... RedOrbit Three Studies Suggest Abbott's HUMIRA (adalimumab) May Improve … - Jun 19, 2007 Rheumatoid arthritis (RA) is one of the most common causes of disability in the Western world. New data released today show that rheumatoid arthritis (RA) ... Medical News Today - Medical News Today (press release) Abbott's Humira® (Adalimumab) Granted FDA Priority Review For The … - Nov 2, 2006 Abbott announced today that the US Food and Drug Administration (FDA) has granted Priority Review for its recent supplemental Biologics License Application ... Medical News Today - Medical News Today (press release) Key IVF doctor witness criticised - Oct 1, 2008 ...that IK alleged Mr Taranissi said she should not complain if she failed to get pregnant or suffered another miscarriage as she had refused Humira, ... BBC News Humira in AS discussed at EULAR congress - Jun 26, 2006 US health care major Abbott Laboratories says that data from a Phase III trial of Humira (adalimumab), its tumor necrosis factor targeting therapeutic in ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Fungus Infected Woman Who Died After Gene Therapy - Aug 17, 2007 One of those in particular, adalimumab, whose brand name is Humira, is known to make patients susceptible to histoplasmosis, the kind of fungal infection ... Washington Post Abbot's Humira Receives Positive Opinion for Treatment of Psoriasis - Nov 19, 2007 Abbot has reported that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, granted a positive ... RedOrbit Abbott's Humira Demonstrates Efficacy in Psoriasis Study - Sep 19, 2008 Abbott has announced new positive data from a sub-analysis of the company's pivotal, 52-week study, Reveal, which demonstrated that more psoriasis patients ... RedOrbit HUMIRA(R) (adalimumab) Receives FDA Approval for First-Line … - Apr 10, 2005 ABBOTT PARK, Ill., Oct. 4 /PRNewswire-FirstCall/ -- Abbott announced today that it received US Food and Drug Administration (FDA) approval to market ... Euro am Sonntag HUMIRA(R) (Adalimumab) Shows Promise in Treating Patients With … - Nov 13, 2005 SAN DIEGO, Nov. 13 /PRNewswire-FirstCall/ -- New data from a subgroup analysis at 12 weeks of the Research in Active Rheumatoid Arthritis (ReAct) study in ... RedOrbit Abbott Receives Positive Opinion for HUMIRA(R) (Adalimumab) As First-... - Jun 27, 2005 ABBOTT PARK, Ill., June 27 /PRNewswire-FirstCall/ -- Abbott today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific ... RedOrbit Cancer risk from arthritis drugs overstated-study - Nov 7, 2006 In May, a study published in the Journal showed that Humira, known generically as adalimumab, and Remicade, known generically as infliximab, ... Reuters Abbott opens new Humira plant Rheumatoid arthritus drug manufactured ... - Apr 11, 2007 To meet the soaring demand for Humira, Abbott Laboratories Tuesday opened a $450 million plant in Puerto Rico to manufacture the rheumatoid arthritis drug ... $2.95 - News Sun - NewsBank Abbott wins new round of approval for Humira | Article from Chicago... - Oct 5, 2005 Abbott wins new round of approval for Humira ... find Chicago Sun-Times articles. Abbott Laboratories landed US regulatory approvals to market its ... Pay-Per-View - Chicago Sun-Times - HighBeam Research Humira wins expanded OK in Europe | Article from Chicago Sun-Times | ... - Aug 16, 2005 Humira wins expanded OK in Europe ... find Chicago Sun-Times articles. Abbott Laboratories landed European regulatory approval to market its blockbuster ... Pay-Per-View - Chicago Sun-Times - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |